Taha Y. Taha
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 5
-
- Histone Deacetylase Inhibitors Research 6
- Protein Degradation and Inhibitors 6
- Ubiquitin and proteasome pathways 2
-
- Bacteriophages and microbial interactions 3
-
- Peptidase Inhibition and Analysis 3
-
- Hepatitis B Virus Studies 3
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Irene P. ChenMélanie OttJennifer M. HayashiAbdullah M. SyedBharath SreekumarAlison CilingTakako TabataJennifer A. Doudna
- Partner nations
- United StatesEgyptDemocratic Republic of the Congo
In The Last Decade
Taha Y. Taha
15 papers receiving 385 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Infectious Diseases 201
- Hepatology 30
- Virology 16
- Animal Science and Zoology 32
- Molecular Biology 194
Countries citing papers authored by Taha Y. Taha
This map shows the geographic impact of Taha Y. Taha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taha Y. Taha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taha Y. Taha more than expected).
Fields of papers citing papers by Taha Y. Taha
This network shows the impact of papers produced by Taha Y. Taha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taha Y. Taha. The network helps show where Taha Y. Taha may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Taha Y. Taha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 31 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 9 | |
| 6 | Rapid assessment of SARS-CoV-2–evolved variants using virus-like particlesbreakdown → | 2021 | 193 |
| 7 | 2020 | 6 | |
| 8 | 2020 | 11 | |
| 9 | 2019 | 7 | |
| 10 | 2019 | 34 | |
| 11 | 2018 | 4 | |
| 12 | 2017 | 9 | |
| 13 | 2017 | 33 | |
| 14 | 2017 | 3 | |
| 15 | 2017 | 30 |
About Taha Y. Taha
Taha Y. Taha is a scholar working on Virology, Infectious Diseases and Animal Science and Zoology, having authored 15 papers that have together received 388 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (6 papers), Protein Degradation and Inhibitors (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Bacteriophages and microbial interactions (3 papers), Peptidase Inhibition and Analysis (3 papers), Hepatitis B Virus Studies (3 papers), Ubiquitin and proteasome pathways (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Infectious Diseases (201 citations), Hepatology (30 citations) and Virology (16 citations). Taha Y. Taha has collaborated with scholars based in United States, Egypt and Democratic Republic of the Congo. Frequent co-authors include Irene P. Chen, Mélanie Ott, Jennifer M. Hayashi, Abdullah M. Syed, Bharath Sreekumar, Alison Ciling, Takako Tabata, Jennifer A. Doudna, Mir M. Khalid and Peiyi Chen. Their work appears in journals such as Science, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.